BIONXT SOLUTIONS INC (BXT.DE) Stock Price, Quote, News and Overview
FRA:BXT - Deutsche Boerse Ag - CA0909741062 - Common Stock - Currency: EUR
BXT.DE Quote, Performance and Key Statistics
FRA:BXT (3/7/2025, 7:00:00 PM)
0.365
-0.01 (-1.88%)
The current stock price of BXT.DE is 0.365 EUR. In the past month the price increased by 34.69%. In the past year, price decreased by -11.62%.
BXT.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LLY.MI | ELI LILLY & CO | 67 | 760.43B | ||
| LLY.DE | ELI LILLY & CO | 66.98 | 760.15B | ||
| ZEG.DE | ASTRAZENECA PLC | 21.82 | 446.45B | ||
| JNJ.DE | JOHNSON & JOHNSON | 16.81 | 372.31B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 16.61 | 367.98B | ||
| NOV.DE | NOVO NORDISK A/S-B | 26.21 | 355.97B | ||
| SNW.DE | SANOFI | 14.32 | 275.64B | ||
| SAN.PA | SANOFI | 14.27 | 274.84B | ||
| 1SAN.MI | SANOFI | 14.19 | 273.18B | ||
| 6MK.DE | MERCK & CO. INC. | 12.64 | 224.82B | ||
| 1MRKX.MI | MERCK & CO. INC. | 12.47 | 221.79B | ||
| PFE.DE | PFIZER INC | 8.69 | 140.81B |
Related stock screener links
About BXT.DE
Company Profile
BioNxt Solutions, Inc. engages in the business of producing, extracting, and selling medical cannabis. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-08-06. The firm is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The firm has research and development operations in North America and Europe, with an operational focus in Germany. The firm is also focused on regulatory approval and commercialization of medical products for European markets. Its diagnostic products include COVID-19 PCR Diagnostic Kit, Peri-Implantitis Oral Biosensor, and H1N1 (Swine Flu) and H5N1 (Avian Flu) Oral Biosensors. Its subsidiaries include XPhyto Laboratories Inc., Bunker Pflanzenextrakte GmbH, Vektor Pharma TF GmbH, BioNxt Europe GmbH, and 3a-diagnostics GmbH, among others.
Company Info
BIONXT SOLUTIONS INC
Suite 270 - 1820 Fir Street
Vancouver BRITISH COLUMBIA CA
Employees: 0
Company Website: https://bionxt.com/
Investor Relations: http://bionxt.com/investors/
Phone: 17808186422
BIONXT SOLUTIONS INC / BXT.DE FAQ
What is the stock price of BIONXT SOLUTIONS INC today?
The current stock price of BXT.DE is 0.365 EUR. The price decreased by -1.88% in the last trading session.
What is the ticker symbol for BIONXT SOLUTIONS INC stock?
The exchange symbol of BIONXT SOLUTIONS INC is BXT and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is BXT.DE stock listed?
BXT.DE stock is listed on the Deutsche Boerse Ag exchange.
What is BIONXT SOLUTIONS INC worth?
BIONXT SOLUTIONS INC (BXT.DE) has a market capitalization of 41.39M EUR. This makes BXT.DE a Nano Cap stock.
How many employees does BIONXT SOLUTIONS INC have?
BIONXT SOLUTIONS INC (BXT.DE) currently has 0 employees.
What are the support and resistance levels for BIONXT SOLUTIONS INC (BXT.DE) stock?
BIONXT SOLUTIONS INC (BXT.DE) has a support level at 0.34. Check the full technical report for a detailed analysis of BXT.DE support and resistance levels.
Should I buy BIONXT SOLUTIONS INC (BXT.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BXT.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BXT.DE, evaluating the profitability, health, valuation and growth aspects
- BIONXT SOLUTIONS INC (BXT.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIONXT SOLUTIONS INC (BXT.DE) Sales and EPS estimates to see what analysts future expectations are.
- BIONXT SOLUTIONS INC (BXT.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIONXT SOLUTIONS INC (BXT.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIONXT SOLUTIONS INC (BXT.DE) Stock Chart to make your own analysis
- BIONXT SOLUTIONS INC (BXT.DE) Latest news and press-releases to stay up to date.
Does BIONXT SOLUTIONS INC (BXT.DE) stock pay dividends?
BXT.DE does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIONXT SOLUTIONS INC (BXT.DE)?
BIONXT SOLUTIONS INC (BXT.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
BXT.DE Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to BXT.DE. When comparing the yearly performance of all stocks, BXT.DE is one of the better performing stocks in the market, outperforming 96.96% of all stocks.
BXT.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BXT.DE. Both the profitability and financial health of BXT.DE have multiple concerns.
BXT.DE Financial Highlights
Over the last trailing twelve months BXT.DE reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 55.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -905.32% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |